Skip to main navigation
Skip to main content
Skip to Footer
US
Sandoz Site Directory
Home
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
Partnerships and Collaborations
Access to Healthcare
About Us
Who We Are
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2019
June
Media Release
/
Jun 27, 2019
Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals
Read More
Media Release
/
Jun 04, 2019
Novartis and Sandoz Honored with Power of Partnership Award
Read More
May
Media Release
/
May 29, 2019
Sandoz launches Fulvestrant Injection, the first generic version of FASLODEX®, in the US
Read More
Media Release
/
May 08, 2019
Update on SYMJEPI™ (epinephrine) in the US
Read More
Featured News
/
May 03, 2019
Food Allergy Awareness Week - Addressing the Medication Shortage
Read More
April
Media Release
/
Apr 03, 2019
Sandoz resubmits biosimilar pegfilgrastim application to US FDA
Read More
March
Media Release
/
Mar 26, 2019
Sandoz exclusively launches treprostinil injection, the first generic version of Remodulin®, in the US
Read More
February
Media Release
/
Feb 19, 2019
Sandoz launches authorized generic version of buprenorphine and naloxone sublingual film
Read More
January
Media Release
/
Jan 31, 2019
Sandoz US recognized as Top Employer for 2019
Read More
Media Release
/
Jan 24, 2019
Sandoz launches Desflurane, the first generic of Suprane®, in the US
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
3
of 5
Page
4
of 5
Current page
5
of 5
Page
6
of 5
Page
7
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›